| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| May 16, 2025 | May 20, 2025 | McCourt Thomas A CEO | Sell | $0.58 | $7,745 | -0.79% |
| May 16, 2025 | May 20, 2025 | Gaskins Tammi L Chief Commercial Officer | Sell | $0.58 | $1,487 | -1.05% |
| Feb 10, 2025 | Feb 13, 2025 | McCourt Thomas A CEO | Sell | $1.76 | $244,753 | -10.70% |
| Feb 10, 2025 | Feb 13, 2025 | Silver Ronald Principal Accounting Officer | Sell | $1.76 | $21,204 | -4.13% |
| Feb 10, 2025 | Feb 13, 2025 | Shetzline Michael SVP CMO Head-Res Drug | Sell | $1.76 | $72,633 | -6.93% |
| Feb 10, 2025 | Feb 13, 2025 | John Minardo GC | Sell | $1.76 | $68,531 | -8.71% |
| Feb 10, 2025 | Feb 13, 2025 | Martini Gregory S. CFO | Sell | $1.76 | $21,212 | -6.15% |
| Nov 18, 2024 | Nov 20, 2024 | Davis Andrew SVP Chief Business Officer | Sell | $4.08 | $21,869 | -1.85% |
| Nov 18, 2024 | Nov 20, 2024 | Emany Sravan Kumar SVP COO CFO | Sell | $4.08 | $44,884 | -3.43% |
| Aug 12, 2024 | Aug 14, 2024 | John Minardo GC | Sell | $4.27 | $42,316 | -3.36% |
| Aug 12, 2024 | Aug 14, 2024 | Silver Ronald Principal Accounting Officer | Sell | $4.27 | $13,267 | -1.92% |
| Jun 10, 2024 | Jun 12, 2024 | McHugh Julie Dir | Sell | $6.29 | $143,198 | -14.03% |
| Jun 06, 2024 | Jun 10, 2024 | Moukheibir Catherine Dir | Sell | $6.47 | $517,694 | -62.19% |
| May 20, 2024 | May 22, 2024 | McCourt Thomas A CEO | Sell | $6.45 | $436,136 | -5.55% |
| May 20, 2024 | May 22, 2024 | Davis Andrew SVP Chief Business Officer | Sell | $6.45 | $146,576 | -7.31% |
| May 20, 2024 | May 22, 2024 | Shetzline Michael CMO SVP Head-Res Drug | Sell | $6.45 | $104,026 | -3.75% |
| May 20, 2024 | May 22, 2024 | John Minardo GC | Sell | $6.45 | $112,256 | -5.58% |
| Mar 06, 2024 | Mar 08, 2024 | Duane Jon R Dir | Buy | $8.7 | $60,204 | +5.41% |
| Mar 04, 2024 | Mar 06, 2024 | Emany Sravan Kumar SVP CFO | Buy | $9.38 | $100,216 | +3.42% |
| Feb 12, 2024 | Feb 15, 2024 | John Minardo GC | Sell | $15.24 | $722,071 | -14.51% |
| Feb 12, 2024 | Feb 15, 2024 | Shetzline Michael CMO SVP Head-Res Drug | Sell | $15.24 | $588,538 | -8.91% |
| Feb 12, 2024 | Feb 15, 2024 | Silver Ronald Principal Accounting Officer | Sell | $15.24 | $120,518 | -4.67% |
| Feb 12, 2024 | Feb 15, 2024 | Davis Andrew SVP Chief Business Officer | Sell | $15.24 | $150,053 | -3.47% |
| Feb 12, 2024 | Feb 15, 2024 | McCourt Thomas A CEO | Sell | $15.24 | $3M | -17.54% |
| Dec 14, 2023 | Dec 18, 2023 | Kessler Marla L Dir | Sell | $11.19 | $111,072 | -9.32% |
| Nov 20, 2023 | Nov 22, 2023 | Davis Andrew SVP Chief Business Officer | Sell | $9.69 | $31,851 | -1.49% |
| Sep 15, 2023 | Sep 18, 2023 | Emany Sravan Kumar SVP CFO | Buy | $8.32 | $300,119 | +16.05% |
| Aug 14, 2023 | Aug 16, 2023 | Silver Ronald Principal Accounting Officer | Sell | $10.04 | $19,839 | -1.45% |
| Aug 14, 2023 | Aug 16, 2023 | John Minardo GC | Sell | $10.04 | $70,732 | -3.54% |
| May 30, 2023 | Jun 01, 2023 | McCourt Thomas A CEO | Sell | $10.7 | $284,962 | -3.39% |